These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 18667844)
1. Elevated expression of UBE2T in lung cancer tumors and cell lines. Hao J; Xu A; Xie X; Hao J; Tian T; Gao S; Xiao X; He D Tumour Biol; 2008; 29(3):195-203. PubMed ID: 18667844 [TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-conjugating enzyme E2T (UBE2T) and denticleless protein homolog (DTL) are linked to poor outcome in breast and lung cancers. Perez-Peña J; Corrales-Sánchez V; Amir E; Pandiella A; Ocana A Sci Rep; 2017 Dec; 7(1):17530. PubMed ID: 29235520 [TBL] [Abstract][Full Text] [Related]
3. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021 [TBL] [Abstract][Full Text] [Related]
4. Expression of hnRNP B1 in four major histological types of lung cancers. Hamasaki M; Kamma H; Wu W; Kaneko S; Fujiwara M; Satoh H; Haraoka S; Kikuchi M; Shirakusa T Anticancer Res; 2001; 21(2A):979-84. PubMed ID: 11396191 [TBL] [Abstract][Full Text] [Related]
5. Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer. Yamaji H; Iizasa T; Koh E; Suzuki M; Otsuji M; Chang H; Motohashi S; Yokoi S; Hiroshima K; Tagawa M; Nakayama T; Fujisawa T Cancer Immunol Immunother; 2004 Sep; 53(9):786-92. PubMed ID: 15185009 [TBL] [Abstract][Full Text] [Related]
6. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma. Matsuda Y; Yamamoto T; Kudo M; Kawahara K; Kawamoto M; Nakajima Y; Koizumi K; Nakazawa N; Ishiwata T; Naito Z Int J Oncol; 2008 Dec; 33(6):1177-85. PubMed ID: 19020750 [TBL] [Abstract][Full Text] [Related]
7. ADAM8 as a novel serological and histochemical marker for lung cancer. Ishikawa N; Daigo Y; Yasui W; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y Clin Cancer Res; 2004 Dec; 10(24):8363-70. PubMed ID: 15623614 [TBL] [Abstract][Full Text] [Related]
8. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas. Sato T; Murakumo Y; Hagiwara S; Jijiwa M; Suzuki C; Yatabe Y; Takahashi M Pathol Int; 2007 Nov; 57(11):719-24. PubMed ID: 17922683 [TBL] [Abstract][Full Text] [Related]
9. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer. Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of p63 expression in lung cancer by use of complementary DNA and tissue microarray]. Yu YW; Garber ME; Schlüns K; Pacyna-Gengelbach M; Petersen I Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):324-7. PubMed ID: 15363316 [TBL] [Abstract][Full Text] [Related]
11. Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas. Zheng H; Tsuneyama K; Takahashi H; Miwa S; Nomoto K; Saito H; Masuda S; Takano Y Anticancer Res; 2007; 27(1B):575-81. PubMed ID: 17348444 [TBL] [Abstract][Full Text] [Related]
12. Reduced transcription of the RB2/p130 gene in human lung cancer. Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097 [TBL] [Abstract][Full Text] [Related]
13. [Study on endothelin-1 positive expression and quantitative analysis in lung cancer]. Yang X; Liu L; Qi H Zhonghua Jie He He Hu Xi Za Zhi; 1998 Feb; 21(2):111-3. PubMed ID: 11263384 [TBL] [Abstract][Full Text] [Related]